Monoclonal antibodies in the treatment of metastatic carcinoma to the liver: report of a pilot study including leukopheresis.
Thirteen patients with metastatic liver carcinoma were treated with hepatic irradiation, leukopheresis and monoclonal antibodies to test the tumoricidal effects of murine 17-1A immunoglobulin G (IgG) Mab. A significant increase in survival for this group of patients was identified.